Pet insurance provider Trupanion (NASDAQ: TRUP) announced better-than-expected revenue in Q3 2026, with sales up 10.5% year on year to $405.6 million. Its GAAP profit of $0.21 per share was 38.2% above analysts’ consensus estimates.

Is now the time to buy TRUP? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Trupanion’s Q3 2026 results were met with a negative market reaction despite exceeding Wall Street’s revenue and GAAP profit expectations. Management attributed the quarter’s performance to record pet acquisition, improved conversion rates, and efficiency in marketing spend. CEO Margi Tooth pointed to the rollout of expanded deductible and coinsurance options and advancements in technology and automation as key drivers supporting higher member retention and lifetime value per pet, stating, “Our long-standing investments in technology, automation, and AI continue to pay off across the business.”

Looking ahead, Trupanion’s management expects continued growth to hinge on balancing investments in technology, product expansion, and pricing discipline amid persistent veterinary cost inflation. They highlighted upcoming launches such as the new digital pet insurance product and the Landspath pet food initiative as long-term growth drivers. However, CEO Margi Tooth cautioned that “we expect to see continues of double-digit inflation in 2027,” signaling that ongoing cost pressures will necessitate careful pricing and retention management. Management’s guidance suggests a focus on maintaining efficiency while expanding the addressable market and strengthening relationships with veterinary partners.

Key insights from management’s remarks

Management pointed to operational execution in new pet acquisition, optimized marketing, and ongoing technology investments as the primary drivers of quarterly performance. Forward-looking strategy centers on broadening product offerings and navigating elevated cost pressures.

• Pet acquisition efficiency: Trupanion achieved record net new pet additions, with 28% year-over-year growth in net pets and improved efficiency in acquisition spend driven by higher web conversion rates and the rollout of new deductible and coinsurance options.
• Retention improvement: Q3 marked the seventh consecutive quarter of increased member retention, attributed to product enhancements and better customer experience, helping to boost per-pet lifetime value and contribution margins.
• Technology and automation impact: Investments in technology, automation, and AI—including the proprietary claims platform and the Scout virtual agent—have increased claims automation from under 15% in 2020 to over 65% in Q3 2026, reducing processing costs and improving scalability.
• Veterinary channel expansion: The company reported its highest quarterly addition of veterinary clinics using its direct payment software in nearly five years, supporting brand differentiation and deepening veterinary relationships.
• Brand and product pipeline: Trupanion advanced its next-generation digital product for a planned launch in the next year and began limited trials of the Landspath portion-controlled pet food initiative, positioning both as future growth levers while maintaining measured investment.

Drivers of future performance

Management expects future growth to be shaped by ongoing investment in technology, new product launches, and disciplined pricing in response to sustained pet healthcare inflation.

• Inflation-driven pricing strategy: Management indicated that double-digit veterinary cost inflation is expected to persist into 2027, requiring ongoing, granular pricing adjustments to maintain value for members and support retention.
• Product and channel expansion: The anticipated mid-2027 launch of a digital pet insurance product and the Landspath pet food initiative are intended to broaden Trupanion’s addressable market and deepen integration with veterinary partners, though near-term revenue impact is expected to be limited.
• Retention and member experience focus: Sustained improvement in member retention—supported by flexible product features, improved onboarding, and direct payment solutions—remains central to offsetting cost pressures and supporting long-term profitability, according to management.

Catalysts in upcoming quarters

Looking ahead, the StockStory team will be monitoring (1) the rollout and early adoption of Trupanion’s digital pet insurance product, (2) progress in the Landspath pet food initiative, including integration with veterinary partners, and (3) management’s ability to sustain member retention and acquisition efficiency despite continued veterinary cost inflation. Execution in these areas will be critical for maintaining operating leverage and long-term growth.

Trupanion currently trades at $31.50, down from $34.72 just before the earnings. Is there an opportunity in the stock? See for yourself in our full research report (it’s free).

Now could be the perfect time to invest in these stocks

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.